Lymphedema: Separating Fact From Fiction - Cancer Network
"..... Recently, Cormier et al found only 47 studies between 1972 and 2008 with
more than 10 patients that prospectively evaluated lymphedema as a
primary or secondary outcome after treatment for melanoma, bladder,
sarcoma, penile, prostate, vulvar, cervical, endometrial, or head and
neck cancers.[2] The authors’ analysis of these studies demonstrated the
overall incidence of lymphedema to be 16.3% after melanoma, 10.1% after
genitourinary cancers, and 19.6% after gynecologic malignancies, and
notes that lymphedema rates are higher when the lower rather than upper
extremity is affected. Given the abundance of breast cancer data, this
review will focus on breast cancer–related lymphedema. However, the
principles and controversies discussed are relevant regardless of the
type of malignancy to which the lymphedema is attributed....."
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.